Vergoeding 2019-2023 voor ATC-subgroep L02BA : Anti-oestrogenen
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| L02BA01 Tamoxifen | 1.334.900 | 1.364.500 | 1.271.500 | 1.476.300 | 1.638.300 |
| L02BA03 Fulvestrant (Faslodex ®) | 9.012.600 | 9.152.400 | 7.655.000 | 7.045.400 | 6.304.500 |
| Totaal | 10.347.500 | 10.516.900 | 8.926.500 | 8.521.700 | 7.942.800 |